dimarts, 19 de maig del 2015

Blood clots prompt trial pause for Edwards' Fortis mitral valve

Edwards Lifesciences halts enrollment in a clinical trial of its Fortis mitral valve implant after some patients developed blood clots in the devices.

Blood clots force trial pause for Edwards' Fortis mitral valve

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Fm3KjG

Cap comentari:

Publica un comentari a l'entrada